Prospective, Randomized, Placebo Controlled Trial of the Efficacy and Safety of Inhaled Nitric Oxide (NO) in Cystic Fibrosis (CF) Patients
Phase of Trial: Phase II
Latest Information Update: 30 Mar 2017
At a glance
- Drugs Nitric oxide (Primary)
- Indications Cystic fibrosis; Cystic fibrosis-associated respiratory tract infections
- Focus Therapeutic Use
- Sponsors Novoteris
- 23 Feb 2017 Status changed from not yet recruiting to recruiting.
- 21 Sep 2016 Planned initiation date changed from 1 Sep 2015 to 1 Nov 2016.
- 21 Sep 2016 Planned End Date changed from 1 Mar 2017 to 1 Dec 2017.